Related Experiment Video
Updated: Apr 27, 2026

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
Published on: August 13, 2015
Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients
Arvind I Srinath1, Alka Goyal, Lori A Zimmerman
1*Department of Pediatric Gastroenterology, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; †Department of Pediatric Gastroenterology, Boston Children's Hospital, Boston, Massachusetts; Departments of ‡Psychiatry, and §Gastroenterology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; ‖Department of Psychiatry, Boston Children's Hospital, Boston, Massachusetts; and ¶Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Insights
Depression significantly impacts abdominal pain in pediatric inflammatory bowel disease (IBD) patients. Treating comorbid depression may reduce pain and prevent unnecessary medical interventions.
Area of Science:
- Pediatric Gastroenterology
- Child and Adolescent Psychiatry
- Inflammatory Bowel Disease Research
Background:
- Pediatric inflammatory bowel disease (IBD) patients frequently experience abdominal pain.
- Depression is a common comorbidity in youth with IBD, exacerbating pain symptoms.
Purpose of the Study:
- To evaluate biological and psychological factors associated with abdominal pain in depressed pediatric IBD patients.
- To identify predictors of abdominal pain in pediatric Crohn's disease (CD) and ulcerative colitis (UC).
Main Methods:
- Screened 765 IBD patients (ages 9-17) for depression over 3 years.
- Assessed abdominal pain, psychological status (depression, anxiety), and biological markers (disease activity, labs) in depressed youth.
Main Results:
- 217 IBD patients were depressed; 163 had pain scores. In Crohn's disease, pain correlated with depression, diarrhea, elevated ESR, low albumin, weight loss, and tenderness. Depression, weight loss, and tenderness predicted pain in CD.
- In ulcerative colitis, pain correlated with depression and nocturnal stools. Depression predicted pain in UC.
Conclusions:
- Psychological state, particularly depression, may heighten abdominal pain sensitivity in pediatric IBD.
- Screening for and treating depression in pediatric IBD patients can potentially reduce excessive medical testing and treatment escalation.
Background:
Pediatric patients with inflammatory bowel disease (IBD) have high rates of abdominal pain. The study aims were to (1) evaluate biological and psychological correlates of abdominal pain in depressed youth with IBD and (2) determine predictors of abdominal pain in Crohn's disease (CD) and ulcerative colitis (UC).
Methods:
Seven hundred sixty-five patients aged 9 to 17 years with IBD seen over 3 years at 2 sites were screened for depression. Depressed youth completed comprehensive assessments for abdominal pain, psychological (depression and anxiety), and biological (IBD-related, through disease activity indices and laboratory values) realms.
Results:
Two hundred seventeen patients with IBD (161 CD, 56 UC) were depressed. One hundred sixty-three (120 CD, 43 UC) patients had complete abdominal pain index scores. In CD, abdominal pain was associated with depression (r = 0.33; P < 0.001), diarrhea (r = 0.34; P = 0.001), erythrocyte sedimentation rate (r = 0.22; P = 0.02), low albumin (r = 0.24; P = 0.01), weight loss (r = 0.33; P = 0.001), and abdominal tenderness (r = 0.38, P = 0.002). A multivariate model with these significant correlates represented 32% of the variance in pain. Only depression (P = 0.03), weight loss (P = 0.04), and abdominal tenderness (P = 0.01) predicted pain for patients with CD. In UC, pain was associated with depression (r = 0.46; P = 0.002) and nocturnal stools (r = 0.32; P = 0.046). In the multivariate model with these significant correlates, 23% of the variance was explained and only depression (P = 0.02) predicted pain.
Conclusions:
The psychological state of pediatric patients with IBD may increase the sensitivity to abdominal pain. Thus, screening for and treating comorbid depression may prevent excessive medical testing and unnecessary escalation of IBD medications.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Clinical Manifestations
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction

